Publications by authors named "Ernest Jan"

Claim this Profile
R
Retinal Vein Occlusion Guidelines.
Jan Studnička, Jan Němčanský, Daniela Vysloužilová, Jan Ernest, Miroslav Veith

Cesk Slov Oftalmol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial.
Susan B Bressler, Abhijit Barve, Prasanna C Ganapathi, Katrin Beckmann, Rajendra S Apte, Jan Ernest

JAMA Ophthalmol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing.
Laurent Kodjikian, Lluís Arias Barquet, András Papp, Peter J Kertes, Edoardo Midena, Jan Ernest

Adv Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial.
SriniVas R Sadda, Mario Bradvica, Attila Vajas, Min Sagong, Jan Ernest, Jan Studnička, Hyerin Jang

BMJ Open Ophthalmol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Biosimilar XSB-001 versus Reference Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration.
Anat Loewenstein, Norbert Czumbel, Jan Ernest, Jaroslava Dusová, Joel Pearlman

Ophthalmol Retina· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial.
Se Joon Woo, Mario Bradvica, Attila Vajas, Min Sagong, Jan Ernest, Jan Studnicka, Hyerin Jang

JAMA Ophthalmol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes.
Neil M Bressler, Miroslav Veith, Jan Hamouz, Jan Ernest, Dominik Zalewski, Jan Studnička

Br J Ophthalmol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
Se Joon Woo, Miroslav Veith, Jan Hamouz, Jan Ernest, Dominik Zalewski, Jan Studnicka

JAMA Ophthalmol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Results of Fixed Aflibercept Treatment Regime in Type 3 Neovascularization.
Jan Ernest, Katerina Manethova, Petr Kolar, Lukas Sobisek, Riccardo Sacconi

Ophthalmologica· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Burden of Macular Diseases in Central and Eastern Europe-Implications for Healthcare Systems.
Polona Jaki Mekjavić, Vilma Jūratė Balčiūnienė, Lala Ćeklić, Jan Ernest, Zuzana Jamrichova

Value Health Reg Issues· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
Katerina Manethova, Jan Ernest, Michal Hrevus

Eur J Ophthalmol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study.
Timothy L Jackson, Usha Chakravarthy, Peter K Kaiser, Jason S Slakter, Ernest Jan

Ophthalmology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Recommendations for diagnosis and therapy of patients with retinal vein occlusion].
Jirí Rehák, Jan Studnicka, Pavel Rozsíval, Sárka Pitrová, Jan Ernest

Cesk Slov Oftalmol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New trends in the ARMD treatment].
Jan Ernest

Cesk Slov Oftalmol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis